Cargando…

Association of Base Excision Repair Gene Polymorphisms with the Response to Chemotherapy in Advanced Non-Small Cell Lung Cancer

BACKGROUND: Base excision repair (BER) plays an important role in the maintenance of genome integrity and anticancer drug resistance. This study aimed to explore the role of BER gene polymorphisms in response to chemotherapy for advanced non-small cell lung cancer (NSCLC) patients treated with plati...

Descripción completa

Detalles Bibliográficos
Autores principales:	Dong, Jie, Wang, Xu, Yu, Yu, Yan, Xu, Cui, Jiu-Wei
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Medknow Publications & Media Pvt Ltd 2018
Materias:	Original Article
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6085862/ https://www.ncbi.nlm.nih.gov/pubmed/30082520 http://dx.doi.org/10.4103/0366-6999.238141

Ejemplares similares

Excision Repair Cross Complementation Group 1 Single Nucleotide Polymorphisms and Nivolumab in Advanced Non-Small Cell Lung Cancer
por: Aiello, Marco Maria, et al.
Publicado: (2020)

MRP2 and GSTP1 polymorphisms and chemotherapy response in advanced non-small cell lung cancer
por: Sun, Ning, et al.
Publicado: (2009)

Associations of Polymorphisms in DNA Repair Genes and MDR1 Gene with Chemotherapy Response and Survival of Non-Small Cell Lung Cancer
por: Du, Yan, et al.
Publicado: (2014)

Excision Repair Cross-Complementation Group 1 Enzyme as a Molecular Determinant of Responsiveness to Platinum-Based Chemotherapy for non Small-Cell Lung Cancer
por: Mountzios, Giannis, et al.
Publicado: (2008)

Association between Single Nucleotide Polymorphisms (SNPs) and Toxicity of Advanced Non-Small-Cell Lung Cancer Patients Treated with Chemotherapy
por: Zhang, Ling, et al.
Publicado: (2012)

Single nucleotide polymorphisms of nucleotide excision repair pathway are significantly associated with outcomes of platinum-based chemotherapy in lung cancer
por: Song, Xiao, et al.
Publicado: (2017)

Observation on the Clinical Effect of Apatinib Combined with Chemotherapy in the Treatment of Advanced Non-Small Cell Lung Cancer
por: Cui, Yu-jie, et al.
Publicado: (2021)

The association of polymorphisms in nucleotide excision repair genes with ovarian cancer susceptibility
por: Zhao, Zhiguang, et al.
Publicado: (2018)

Nucleotide Excision Repair Factor XPC Ameliorates Prognosis by Increasing the Susceptibility of Human Colorectal Cancer to Chemotherapy and Ionizing Radiation
por: Hu, Liang-Bo, et al.
Publicado: (2018)

Entinostat Enhances the Efficacy of Chemotherapy in Small Cell Lung Cancer Through S-phase Arrest and Decreased Base Excision Repair
por: Solta, Anna, et al.
Publicado: (2023)

Phase II trial of sequential gefitinib after minor response or partial response to chemotherapy in Chinese patients with advanced non-small-cell lung cancer
por: Xu, Jian Ming, et al.
Publicado: (2006)

Excision Repair Cross-Complementation Group 6 Gene Polymorphism Is Associated with the Response to FOLFIRINOX Chemotherapy in Asian Patients with Pancreatic Cancer
por: Choi, Young Hoon, et al.
Publicado: (2021)

Associations between polymorphisms in genes of base excision repair pathway and lung cancer risk
por: Liu, Shiqing, et al.
Publicado: (2020)

Polymorphism of the DNA Base Excision Repair Genes in Keratoconus
por: Wojcik, Katarzyna A., et al.
Publicado: (2014)

Association between DNA mismatch repair gene polymorphisms and platinum-based chemotherapy toxicity in non-small cell lung cancer patients
por: Liu, Jun-Yan, et al.
Publicado: (2017)

Polymorphisms of BCL2 and BAX Genes Associate with Outcomes in Advanced Non-small cell lung cancer Patients treated with platinum-based Chemotherapy
por: Peng, Yu, et al.
Publicado: (2015)

Chemotherapy in non-small cell lung cancer: opportunities for advancement
por: Akhtari, Mani, et al.
Publicado: (2016)

Effect of GSTP1 and ABCC2 Polymorphisms on Treatment Response in Patients with Advanced Non-Small Cell Lung Cancer Undergoing Platinum-Based Chemotherapy: A Study in a Chinese Uygur Population
por: Han, Zhi-Gang, et al.
Publicado: (2017)

Efficacy of Pemetrexed-based Chemotherapy in Comparison to Non-Pemetrexed-based Chemotherapy in Advanced, ALK+ Non-Small Cell Lung Cancer
por: Jo, Jaemin, et al.
Publicado: (2018)

Genetic polymorphisms in the nucleotide excision repair pathway and lung cancer risk: A meta-analysis
por: Kiyohara, Chikako, et al.
Publicado: (2007)

OGG1 in Lung—More than Base Excision Repair
por: Ma, Xiaodi, et al.
Publicado: (2022)

Polymorphisms of Nucleotide Excision Repair Genes Predict Melanoma Survival
por: Li, Chunying, et al.
Publicado: (2013)

Base Excision Repair Gene Polymorphisms and Wilms Tumor Susceptibility
por: Zhu, Jinhong, et al.
Publicado: (2018)

Impact of Polymorphism in Base Excision Repair and Nucleotide Excision Repair Genes and Risk of Cervical Cancer: A Case-Control Study
por: Datkhile, Kailas D, et al.
Publicado: (2022)

Cost‐effectiveness analysis of first‐line treatments for advanced epidermal growth factor receptor‐mutant non‐small cell lung cancer patients
por: Li, Wen‐Qian, et al.
Publicado: (2021)

Polymorphisms in the Gene Encoding Caspase 8 May Predict the Response to First-Line Platinum-Based Chemotherapy in Locally Advanced or Advanced Non-Small-Cell Lung Cancer
por: Szczyrek, Michał, et al.
Publicado: (2021)

Circulating tumor cells dynamics during chemotherapy predict survival and response in advanced non-small-cell lung cancer patients
por: Wang, Zhen, et al.
Publicado: (2023)

Base excision repair imbalance in colorectal cancer has prognostic value and modulates response to chemotherapy
por: Leguisamo, Natalia M., et al.
Publicado: (2017)

Tumor Mutation Burden Correlates With Efficacy of Chemotherapy/Targeted Therapy in Advanced Non–Small Cell Lung Cancer
por: Lin, Chen, et al.
Publicado: (2020)

Polymorphisms in base-excision & nucleotide-excision repair genes & prostate cancer risk in north Indian population
por: Mandal, Raju K., et al.
Publicado: (2012)

Cost-effectiveness of cemiplimab plus chemotherapy versus chemotherapy for the treatment of advanced non-small cell lung cancer
por: Liang, Xueyan, et al.
Publicado: (2023)

Effect of the ERCC1 (C118T) Polymorphism on Treatment Response in Advanced Non-Small Cell Lung Cancer Patients Undergoing Platinum-Based Chemotherapy
por: Kaewbubpa, Walennee, et al.
Publicado: (2016)

The prospect of immunotherapy combined with chemotherapy in patients with advanced non-small cell lung cancer: a narrative review
por: Ning, Xiangu, et al.
Publicado: (2021)

A case-control study on association of nucleotide excision repair polymorphisms and its interaction with environment factors with the susceptibility to non-melanoma skin cancer
por: Li, Yan-Ling, et al.
Publicado: (2017)

Nucleotide excision repair pathway gene polymorphisms are linked to breast cancer risk in a Chinese population
por: He, Bang-shun, et al.
Publicado: (2016)

Small-scale extracts for the study of nucleotide excision repair and non-homologous end joining
por: Smeaton, Michael B., et al.
Publicado: (2007)

XRCC3 Thr241Met Is Associated with Response to Platinum-Based Chemotherapy but Not Survival in Advanced Non-Small Cell Lung Cancer
por: Qiu, Mantang, et al.
Publicado: (2013)

Comparison of bevacizumab plus chemotherapy with chemotherapy alone in advanced non-small-lung cancer patients
por: Tang, Ning, et al.
Publicado: (2016)

OPN Polymorphism Is Related to the Chemotherapy Response and Prognosis in Advanced NSCLC
por: Hao, Yanzhang, et al.
Publicado: (2014)

Radiofrequency deep hyperthermia combined with chemotherapy in the treatment of advanced non-small cell lung cancer
por: Yang, Wen-Hui, et al.
Publicado: (2019)

Cannot write session to /tmp/vufind_sessions/sess_nncu0vpra7ptk3dco21dcu11u3